NO894295L - Fremgangsmaate for behandling av interstitiell cystitt. - Google Patents

Fremgangsmaate for behandling av interstitiell cystitt.

Info

Publication number
NO894295L
NO894295L NO89894295A NO894295A NO894295L NO 894295 L NO894295 L NO 894295L NO 89894295 A NO89894295 A NO 89894295A NO 894295 A NO894295 A NO 894295A NO 894295 L NO894295 L NO 894295L
Authority
NO
Norway
Prior art keywords
cystite
interstitially
procedure
treatment
naltrexone
Prior art date
Application number
NO89894295A
Other languages
English (en)
Norwegian (no)
Other versions
NO894295D0 (no
Inventor
Fred P Sherman
Original Assignee
Baker Cummins Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Cummins Pharma filed Critical Baker Cummins Pharma
Publication of NO894295D0 publication Critical patent/NO894295D0/no
Publication of NO894295L publication Critical patent/NO894295L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Threshing Machine Elements (AREA)
NO89894295A 1988-11-01 1989-10-27 Fremgangsmaate for behandling av interstitiell cystitt. NO894295L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/265,575 US4877791A (en) 1988-11-01 1988-11-01 Method of treatment for interestitial cystitis

Publications (2)

Publication Number Publication Date
NO894295D0 NO894295D0 (no) 1989-10-27
NO894295L true NO894295L (no) 1990-05-02

Family

ID=23011021

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89894295A NO894295L (no) 1988-11-01 1989-10-27 Fremgangsmaate for behandling av interstitiell cystitt.

Country Status (11)

Country Link
US (1) US4877791A (ja)
EP (1) EP0367533B1 (ja)
JP (1) JPH07556B2 (ja)
AT (1) ATE102830T1 (ja)
AU (1) AU623189B2 (ja)
CA (1) CA2001996C (ja)
DE (1) DE68913907T2 (ja)
DK (1) DK541189A (ja)
HK (1) HK119994A (ja)
NO (1) NO894295L (ja)
ZA (1) ZA897823B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases
US4994466A (en) * 1990-06-14 1991-02-19 Baker Cummins Pharmaceuticals, Inc. Method of treatment for multiple sclerosis
US5057322A (en) * 1990-08-10 1991-10-15 Baker Cummins Dermatologicals, Inc. Method of treating mast cell disease
US5145859A (en) * 1991-03-20 1992-09-08 Case Western Reserve University Methods of treating interstitial cystitis and urethral syndrome
ATE259232T1 (de) 1995-03-03 2004-02-15 Endo Pharmaceuticals Inc Verwendung von dextromethorphan oder dextrorphan zur behandlung der harninkontinenz
US5878750A (en) * 1996-11-14 1999-03-09 Clemens; Anton H. Method of treating the syndrome of coronary heart disease risk factors in humans
US6203813B1 (en) 1997-01-13 2001-03-20 Lance L. Gooberman Pharmaceutical delivery device and method of preparation therefor
EP1150699A4 (en) * 1999-02-01 2004-06-30 John Lezdey TREATMENT OF BLADDER AND GASTROINTESTINAL MASTO CYTOSIS
US6262062B1 (en) 2000-08-15 2001-07-17 Cpd, Llc Method of treating the syndrome of coronary heart disease risk factors in humans
US6846831B2 (en) 2000-08-15 2005-01-25 Cpd, Llc Method of treating the syndrome of lipodystrophy
US6528520B2 (en) * 2000-08-15 2003-03-04 Cpd, Llc Method of treating the syndrome of coronary heart disease risk factors in humans
WO2002081477A1 (fr) * 2001-03-30 2002-10-17 Toray Industries, Inc. Derives morphinane 7-substitues et leur utilisation medicinale
US7501433B2 (en) * 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US6972291B2 (en) * 2002-07-02 2005-12-06 Bernstein Richard K Method for reducing food intake
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
ES2913483T3 (es) * 2006-04-03 2022-06-02 Ceva Animal Health Pty Ltd Formulaciones estabilizadas de polisulfato de pentosano (PPS)
BRPI0923450A2 (pt) * 2008-12-16 2015-07-28 Hills Pet Nutrition Inc Métodos para inibir trajetos relacionados à histamina em um animal doméstico, e, para tratar cistite idiopática ou cistite intersticial em um animal doméstico.
US20190358209A1 (en) * 2018-05-25 2019-11-28 Adamis Pharmaceuticals Corporation Drug compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51145B1 (en) * 1980-03-07 1986-10-15 Efamol Ltd Pharmaceutical and dietary compositions
JPS63501717A (ja) * 1985-10-29 1988-07-14 ベーカー・カミンス・デルマトロジカルス・インコーポレーテッド 抗原誘発性アレルギ−反応を阻止するための方法および組成物
FR2609632B1 (fr) * 1987-01-21 1991-03-29 Shelly Marc Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage
US4880813A (en) * 1988-07-22 1989-11-14 Baker Cummins Pharmaceuticals, Inc. Method of treatment for allergic rhinitis
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases

Also Published As

Publication number Publication date
DE68913907T2 (de) 1994-06-23
JPH02188525A (ja) 1990-07-24
ATE102830T1 (de) 1994-04-15
CA2001996A1 (en) 1990-05-01
EP0367533A2 (en) 1990-05-09
US4877791A (en) 1989-10-31
NO894295D0 (no) 1989-10-27
ZA897823B (en) 1990-07-25
EP0367533A3 (en) 1991-10-02
AU623189B2 (en) 1992-05-07
CA2001996C (en) 1996-07-23
AU4385089A (en) 1990-05-10
JPH07556B2 (ja) 1995-01-11
DE68913907D1 (de) 1994-04-21
DK541189D0 (da) 1989-10-30
DK541189A (da) 1990-05-02
EP0367533B1 (en) 1994-03-16
HK119994A (en) 1994-11-11

Similar Documents

Publication Publication Date Title
ZA899028B (en) Compound for treatment for autoimmune diseases
NO894295L (no) Fremgangsmaate for behandling av interstitiell cystitt.
EP0377272A3 (en) Use of nalmefene or naltrexone in the manufacture of a medicament for the treatment of inflammation in an arthritic disease or associated inflammatory diseases
EP0449247A3 (en) Pharmaceutical composition containing galanthamine for treating alcoholism
PH23867A (en) Method of treating parkinson's disease using indolone derivatives
HUT58520A (en) Process for producing pharmaceutical composition suitable for treating impotence
AU1189688A (en) Utilization of morphine antagonists in the preparation of drugs having an immunomodulator and antiviral effect, particularly for treating acquired immunodeficiency states
ATE78687T1 (de) Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen.
ES2093357T3 (es) Metodo de tratamiento de la alopecia.
EP0319962A3 (en) Piperidinyl methanol derivatives for the treatment of anxiety
GR3025518T3 (en) Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus
AU8166291A (en) Method of treating mast cell disease
IT9086204A0 (it) Metodo per la cura dell'impotenza erettiva maschile
GR900300082T1 (en) Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine
FI900098A0 (fi) Menetelmä lääkeaineena käyttökelpoisten 5H-pyrido/1',2':4,5/tiadiatsino/2,3-a/bentsimidatsoliumjohdannaisten valmistamiseksi
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
IT8323253A0 (it) Preparato per la cura della crisi da astinenza nei tossicodipendenti.